Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 8350338)

1.

Serial measurement of soluble interleukin 2 receptor levels: an early indicator of treatment response for Lyme disease.

Fawcett PT, Rose CD, Proujansky R, Gibney KM, Molloy DM, Doughty RA.

J Rheumatol. 1993 Jun;20(6):996-8.

PMID:
8350338
2.

Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis.

Codolo G, Amedei A, Steere AC, Papinutto E, Cappon A, Polenghi A, Benagiano M, Paccani SR, Sambri V, Del Prete G, Baldari CT, Zanotti G, Montecucco C, D'Elios MM, de Bernard M.

Arthritis Rheum. 2008 Nov;58(11):3609-17. doi: 10.1002/art.23972.

3.

Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a/2b patients with chronic hepatitis C.

Abe S, Narita R, Matsuhashi T, Oto T, Tabaru A, Otsuki M.

Eur J Gastroenterol Hepatol. 2008 May;20(5):373-8. doi: 10.1097/MEG.0b013e3282f43aae.

PMID:
18403937
4.

Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis.

Kannian P, McHugh G, Johnson BJ, Bacon RM, Glickstein LJ, Steere AC.

Arthritis Rheum. 2007 Dec;56(12):4216-25.

6.
8.

IgE anti-Borrelia burgdorferi components (p18, p31, p34, p41, p45, p60) and increased blood CD8+CD60+ T cells in children with Lyme disease.

Bluth MH, Robin J, Ruditsky M, Norowitz KB, Chice S, Pytlak E, Nowakowski M, Durkin HG, Smith-Norowitz TA.

Scand J Immunol. 2007 Apr;65(4):376-82.

PMID:
17386029
9.

[Diagnosis and treatment of Lyme arthritis].

Przytuła L, Gińdzieńska-Sieśkiewicz E, Sierakowski S.

Przegl Epidemiol. 2006;60 Suppl 1:125-30. Review. Polish.

PMID:
16909789
10.

Persistent joint swelling and Borrelia-specific antibodies in Borrelia garinii-infected mice after eradication of vegetative spirochetes with antibiotic treatment.

Yrjänäinen H, Hytönen J, Söderström KO, Oksi J, Hartiala K, Viljanen MK.

Microbes Infect. 2006 Jul;8(8):2044-51. Epub 2006 May 30.

PMID:
16797205
11.

Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis.

Fleming RV, Marques AR, Klempner MS, Schmid CH, Dally LG, Martin DS, Philipp MT.

Eur J Clin Microbiol Infect Dis. 2004 Aug;23(8):615-8. Epub 2004 Jul 8.

PMID:
15243815
12.

Long term and repeated electron microscopy and PCR detection of Borrelia burgdorferi sensu lato after an antibiotic treatment.

Honegr K, Hulínská D, Beran J, Dostál V, Havlasová J, Cermáková Z.

Cent Eur J Public Health. 2004 Mar;12(1):6-11.

PMID:
15068199
13.

Good outcomes of Lyme arthritis in 24 patients in an endemic area of Switzerland.

Renaud I, Cachin C, Gerster JC.

Joint Bone Spine. 2004 Jan;71(1):39-43.

PMID:
14769519
14.
15.

[INF-gamma and GM-CSF concentrations in serum of patients with Lyme disease].

Izycka A, Jabłońska E, Zajkowska J, Hermanowska-Szpakowicz T.

Pol Merkur Lekarski. 2002 Dec;13(78):459-61. Polish.

PMID:
12666440
16.
17.

Treatment of patients with persistent symptoms and a history of Lyme disease.

McCaulley ME.

N Engl J Med. 2001 Nov 8;345(19):1424; author reply 1425. No abstract available.

PMID:
11794181
18.

Analysis of some peripheral blood lymphocyte subsets in relation to Borrelia burgdorferi antibodies in patients with Lyme disease.

Zajkowska JM, Hermanowska-Szpakowicz T, Wysocka J, Kondrusik M, Pancewicz SA, Grygorczuk S.

Rocz Akad Med Bialymst. 2000;45:184-98.

PMID:
11712430
20.

Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans.

Philipp MT, Bowers LC, Fawcett PT, Jacobs MB, Liang FT, Marques AR, Mitchell PD, Purcell JE, Ratterree MS, Straubinger RK.

J Infect Dis. 2001 Oct 1;184(7):870-8. Epub 2001 Aug 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk